Contact | Print version | PDF version | Send article | RSS feed

Generex Awarded New Patent in Morocco

14 Apr 2009 - Generex Biotechnology Corporation announced that it has received a new patent in Morocco. The Moroccan Industrial and Commercial Property Office granted the Company its first Moroccan patent, titled "Orally Absorbed Pharmaceutical Formulation and Method of Administration." The patent contains claims to pharmaceutical formulations effective to deliver a pharmaceutical agent across oral membranes as well as device and method claims.
 
"While our regulatory scope in the Middle East region expands, the granting of this application in Morocco is a timely one," said Rose Perri, the Company's Chief Operating Officer. "We look forward to other patent grants that will augment the value of our increasing intellectual property portfolio.”
 
Generex currently holds an aggregate of 143 patents worldwide (21 of which are United States patents) and has an aggregate of 119 patent applications pending in various jurisdictions.